Viloxazine HCl |
Capsule (Extended Release) |
II (Paddle) with sinker |
50 |
pH 6.8 Phosphate Buffer |
900 |
1, 2, 4, 6, 8, 10, 12 and 16 hours |
2022/07/07 |
Vismodegib |
Capsule |
II (Paddle) |
75 |
0.01 N HCl with 1.0% sodium lauryl sulfate (SLS) |
900 |
10, 15, 20, 30 and 45 |
2015/05/28 |
Voclosporin |
Capsule |
II (Paddle) |
75 |
0.75% of Polyoxyl 40 hydrogenated castor oil in sodium acetate buffer (22mM), pH 4.5 |
900 |
10, 20, 30, 45 and 60 |
2023/02/09 |
Vorapaxar Sulfate |
Tablet |
II (Paddle) |
50 |
41 mM Na2HPO4, 1.5% Citric Acid, pH 3.0 ± 0.5 |
900 |
5, 10, 20, 30, 45 and 60 |
2015/12/24 |
Voriconazole |
Suspension |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 20, 30 and 45 |
2007/01/03 |
Voriconazole |
Tablet |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 20, 30 and 45 |
2008/11/25 |
Vorinostat |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Vortioxetine HBr |
Tablet |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 15, 20, 30 and 45 |
2015/05/28 |
Voxelotor |
Tablet |
II (Paddle) |
75 |
50 mM phosphate buffer (pH 6.8) with 2% sodium lauryl sulfate (SLS) |
900 |
5, 10, 20, 30 and 45 |
2022/07/28 |
Voxelotor |
Tablet, for Suspension |
II (Paddle) |
75 |
50 mM phosphate buffer (pH 6.8) with 2% sodium lauryl sulfate (SLS) |
900 |
5, 10, 15, 20 and 30 |
2022/07/28 |
Warfarin Sodium |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
Zafirlukast |
Tablet |
II (Paddle) |
50 |
1% w/v Aqueous Sodium Dodecyl Sulfate |
1000 |
10. 30, 30 and 45 |
2007/10/09 |
Zalcitabine |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
Zaleplon |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Zidovudine |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Zileuton |
Tablet (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Zileuton |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Zinc Acetate |
Capsule |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 20, 30 and 45 |
2004/02/19 |
Ziprasidone HCl |
Capsule |
II (Paddle) |
75 |
Tier I: 0.05 M Na phosphate buffer, pH 7.5 + 2% SDS (w/w)
Tier II: 0.05 M Na phosphate buffer, pH 7.5 (700ml) + 1% pancreatin. After 15 min. incubation, add 200 mL of phosphate buffer containg 9% SDS |
900 |
10, 20, 30, 45 and 60 |
2006/03/04 |
Zolmitriptan |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |